Identification of new cytotoxic T-cell epitopes on the 38-Kilodalton lipoglycoprotein of Mycobacteriurn tuberculosis by using lipopeptides

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3190-3197

  Da Fonseca, Dora P A J ^a,f   Joosten, Dianne ^a   Van Der Zee, Ruurd ^b   Jue, Danny L ^c   Singh, Mahavir ^d   Vordermeier, Hans M ^e   Snippe, Harm ^a   Verheul, André F M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Department of Infectious Diseases and Immunology   (Netherlands)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^e VETERINARY LABORATORIES AGENCY   (United Kingdom)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOLIPOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; FEMALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VACCINATION;

EID: 0031867796     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3190-3197.1998     Document Type: Article

References (47)

1. Bachmann, M. F., A. Oxenius, H. Pircher, H. Hengartner, P. A. Ashton-Richardt, S. Tonegawa, and R. M. Zinkernagel. 1995. TAP1-independent loading of class I molecules by exogenous viral proteins. Eur. J. Immunol. 25:1739-1743.
2. Bloom, R. B., and C. J. L. Murray. 1992. Tuberculosis: commentary on a reemergent killer. Science 257:1055-1064.
3. Catipovic, B., J. Dal Porto, M. Mage, T. E. Johansen, and J. P. Schneck. 1992. Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176:1611-1618.
4. Delibero, G., I. Flesh, and S. H. E. Kauffman. 1988. Mycobacteria-reactive Lyt-2+ T cell lines. Eur. J. Immunol. 18:59-66.
5. Deres, K., H. Schild, K.-H. Weismuller, G. Jung, and H.-G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561-564.
6. Earnest, M., and J. A. Sbarbaro. 1993. A plague returns. Sciences Sept./Oct.: 14-19.
7. Eberl, G., A. Sabbatini, C. Servis, P. Romero, J. L. Maryanski, and G. Corradin. 1993. MHC class I H-2kd-restricted antigenic peptides: additional constraints for the binding motif. Int. Immunol. 5:1489-1492.
8. Engelhard, V. H. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:13-23.
9. Feltkamp, M. C. W., H. L. Smits, M. P. M. Vierboom, R. P. Minnaar, B. M. de Jongh, J. W. Drijfhout, J. der Schegget, C. J. M. Melief, and W. M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23:2242-2249.
10. Feltkamp, M. C. W., M. P. M. Vierboom, W. M. Kast, and C. J. M. Melief. 1994. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol. Immunol. 31:1391-1401.
11. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 89:12013-12017.
12. Kaleab, B., T. Ottenoff, P. Converse, E. Halapi, G. Tadesse, M. Rottenberg, and R. Kiessling. 1990. Mycobacterial-induced cytoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur. J. Immunol. 20:2651-2659.
13. Kauffman, S. H. E. 1988. CD8+ lymphocytes in intracellular microbial infections. Immunol. Today 9:168-174.
14. Kauffman, S. H. E. 1993. Tuberculosis, the role of the immune system. Immunologist 1:109-114.
15. Koch-Weser, D. 1993. BCG vaccination, can it contribute to tuberculosis control? Chest 103:1641-1642.
16. Lipford, G. B., S. Bauer, H. Wagner, and K. Heeg. 1995. In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability. Vaccine 13:313-320.
17. Ljunggren, H.-G., N. J. Stam, C. Ohlen, J. J. Neefjes, P. Hoglund, M.-T. Heemels, J. Bastin, T. N. M. Schumacher, A. Towsend, K. Karre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476-480.
18. Martinon, F., H. Gras-Mass, C. Boutillon, F. Chirat, B. Deprez, J.-G. Guillet, E. Gomard, A. Tartar, and J.-P. Levy. 1992. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. J. Immunol. 149:3416-3422.
19. Ottenhoff, T. H. M., and T. Mutis. 1995. Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections. Eur. J. Clin. Invest. 25:371-377.
20. Pancre, V., H. Gras-Mass, A. Delanoye, J. Hernot, A. Capron, and C. Auriault. 1996. Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide. Scand. J. Immunol. 44:485-492.
21. Pfeifer, J. D., M. J. Wick, R. L. Roberts, K. Findlay, S. J. Normark, and C. V. Hardig. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-362.
22. Rees, A., A. Scoging, A. Mehlert, D. B. Young, and J. Ivanyi. 1988. Specificity of proliferative response of human CD8 clones to mycobacterial antigens. Eur. J. Immunol. 18:1881-1887.
23. Romero, P., J. L. Maryanski, G. Corradin, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323-326.
24. Romero, P., G. Eberl, J. Casanova, A. Cordey, C. Widmann, I. F. Luescher, G. Corradin, and J. L. Maryanski. 1992. Immunization with synthetic peptides containing a defined malaria epitope induces highly diverse cytotoxic T lymphocyte responses. J. Immunol. 148:1871-1878.
25. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929-937.
26. Schild, H., K. Deres, K.-H. Weismuller, G. Jung, and H.-G. Rammensee. 1991. Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. Eur. J. Immunol. 21:2649-2654.
27. Schirmbeck, R., K. Melber, and J. Reimann. 1995. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 25:1063-1070.
28. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M.-F. del Guercio, S. Southwood, R. T. Kubo, R. W. Chesnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
29. Song, R., and C. V. Harding. 1996. Roles of proteasomes, transporter for antigen presentation (TAP), and β2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J. Immunol. 156:4182-4190.
30. Stewart, G. M., and J. D. Young. 1984. Solid-phase peptide synthesis, 2nd ed. Pierce Chemical Co., Rockford, Ill.
31. Tascon, R. E., M. J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D. B. Lowrie. 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2:888-892.
32. Turner, J., and H. M. Dockrell. 1996. Stimulation of human peripheral blood mononuclear cells with live M. bovis-BCG activates cytolytic CD8+ T cells in vitro. Immunology 87:339-342.
33. Verheul, A. F. M., V. Udhayakumar, D. L. Jue, R. M. Wohlhueter, and A. A. Lal. 1995. Monopalmitic acid-peptide conjugates induce cytotoxic T cell responses against malarial epitopes: importance of spacer amino acids. J. Immunol. Methods 182:219-226.
34. Vordermeier, H. M., D. P. Harris, E. Román, R. Lathigra, C. Moreno, and J. Ivanyi. 1991. Identification of T cell stimulatory peptides from the 38-kDa protein of Mycobacterium tuberculosis. J. Immunol. 147:1023-1029.
35. Vordermeier, H. M., D. P. Harris, G. Friscia, E. Román, H. M. Surcel, C. Moreno, G. Pasvol, and J. Ivanyi. 1992. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. Eur. J. Immunol. 22:2631-2637.
36. Vordermeier, H. M., D. P. Harris, C. Moreno, M. Singh, and J. Ivanyi. 1995. The nature of the immunogen determines the specificity of antibodies and T cells to selected peptides of the 38-kDa mycobacterial antigen. Int. Immunol. 4:559-566.
37. Vordermeier, H. M., A. G. A. Coombes, P. Jenkins, J. P. McGee, D. T. O'Hagan, S. S. Davis, and M. Singh. 1995. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine 13:1576-1582.
38. Vordermeier, H. M., X. Zhu, and D. P. Harris. 1997. Induction of CD8+ CTL recognizing mycobacterial peptides. Scand. J. Immunol. 45:521-526.
39. Weismuller, K.-H., G. Jung, and G. Hess. 1989. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine 7:29-33.
40. Weismuller, K.-H., G. Jung, L. C. Gillessen, W. G. Bessler, and W. G. Boltz. 1991. The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant. Immunology 72:109-113.
41. Weismuller, K.-H., W. G. Bessler, and G. Jung. 1992. Solid-phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response. Int. J. Pept. Protein Res. 40:255-260.
42. Young, D., L. Kent, A. Rees, J. Lamb, and J. Ivanyi. 1986. Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis. Infect. Immun. 54:177-183.
43. Young, D. B., and T. R. Garbe. 1991. Lipoprotein antigens of Mycobacterium tuberculosis. Res. Microbiol. 142:55-65.
44. Zhou, X., U. M. Abdel Motal, L. Berg, and M. Jondal. 1992. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides Eur. J. Immunol. 22:3085-3090.
45. Zhou, X., L. Berg, U. M. Abdel Motal, and M. Jondal. 1992. In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. J. Immunol. Methods 153:193-200.
46. Zhu, X., N. Venkataprasad, H. S. Thangaraj, M. Hill, M. Singh, J. Ivanyi, and H. M. Vordermeier. 1997. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:5921-5926.
47. b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis. Int. Immunol. 9:1669-1676.